Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1984 Mar 15;218(3):703–711. doi: 10.1042/bj2180703

Development of a non-extracted 'two-site' immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies.

S C Hodgkinson, B Allolio, J Landon, P J Lowry
PMCID: PMC1153398  PMID: 6326745

Abstract

The development of a 'two-site' immunoradiometric assay (i.r.m.a.) for the direct estimation of human corticotropin-(1-39)-peptide in plasma is described. The assay is based on the simultaneous addition of 125I-labelled sheep anti-(N-terminal corticotropin) IgG (immunoglobulin G) antibodies and rabbit anti-(C-terminal corticotropin) antiserum to standards and unknowns (0.5 ml) followed by 18h incubation. The use of solid-phase reagents was avoided in order to minimize non-specific effects and the time required for reactants to reach equilibrium. Instead, the separation of corticotropin-bound from free labelled antibody is achieved by the addition of sheep anti-(rabbit IgG) antiserum, which precipitates bound labelled antibody by complex-formation with rabbit anti-corticotropin antibodies, which are also hormone-bound. Several 125I-labelled sheep anti-(N-terminal corticotropin) IgG preparations were assessed in the i.r.m.a. Although each was derived from antisera raised to a thyroglobulin conjugate of synthetic corticotropin-(1-24)-peptide (Synacthen), purification of immunoglobulins before iodination by selective immunoadsorption resulted in preparations with distinct specificities which demonstrated marked differences in binding to intact human corticotropin-(1-39)-peptide. These preparations are compared in combination with two rabbit anti-(C-terminal corticotropin) antisera. A 'two-site' assay based on the use of 125I-labelled sheep anti-[ corticotropin-(2-16)-peptide] IgG and rabbit anti-[corticotropin-(34-39)-peptide] antiserum was optimized, since steric inhibition of antibody binding was avoided with this combination and because the measurement of only intact human corticotropin-(1-39)-peptide and not fragments was assured by the use of terminal antibodies. This i.r.m.a. is characterized by rapid equilibration of reactants, a wide 'operating range' (the precision of dose estimates was less than 4% over the range 30-2200 pg/ml) and high sensitivity [8 pg of corticotropin/ml (95% confidence interval 3.7-12.0) (4 pg minimal detectable mass) can be detected directly in plasma].

Full text

PDF
705

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEAVEN D. W., ESPINER E. A., HART D. S. THE SUPPRESSION OF CORTISOL SECRETION BY STEROIDS, AND RESPONSE TO CORTICOTROPHIN, IN SHEEP WITH ADRENAL TRANSPLANTS. J Physiol. 1964 Jun;171:216–230. doi: 10.1113/jphysiol.1964.sp007373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berson S. A., Yalow R. S. Radioimmunoassay of ACTH in plasma. J Clin Invest. 1968 Dec;47(12):2725–2751. doi: 10.1172/JCI105955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Donald R. A. Application of the coated charcoal separation method to the radio-immunoassay of plasma corticotrophin. J Endocrinol. 1968 Aug;41(4):499–508. doi: 10.1677/joe.0.0410499. [DOI] [PubMed] [Google Scholar]
  4. Fleischer N., Givens J. R., Abe K., Nicholson W. E., Liddle G. W. Studies of ACTH antibodies and their reactions with inactive analogues of ACTH. Endocrinology. 1966 May;78(5):1067–1075. doi: 10.1210/endo-78-5-1067. [DOI] [PubMed] [Google Scholar]
  5. Hodgkinson S. C., Lowry P. J. Selective elution of immunoadsorbed anti-(human prolactin) immunoglobulins with enhanced immunochemical properties. Biochem J. 1982 Sep 1;205(3):535–541. doi: 10.1042/bj2050535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Holdaway I. M., Rees L. H., Landon J. Circulating corticotrophin levels in severe hypopituitarism and in the neonate. Lancet. 1973 Nov 24;2(7839):1170–1171. doi: 10.1016/s0140-6736(73)92938-3. [DOI] [PubMed] [Google Scholar]
  7. Hunter W. M., Budd P. S. Immunoradiometric versus radioimmunoassay: a comparison using alpha-fetoprotein as the model analyte. J Immunol Methods. 1981;45(3):255–273. doi: 10.1016/0022-1759(81)90304-5. [DOI] [PubMed] [Google Scholar]
  8. Imura H., Sparks L. L., Grodsky G. M., Forsham P. H. Immunologic studies of adrenocorticotropic hormone (ACTH): dissociation of biologic and immunologic activities. J Clin Endocrinol Metab. 1965 Oct;25(10):1361–1369. doi: 10.1210/jcem-25-10-1361. [DOI] [PubMed] [Google Scholar]
  9. Salacinski P. R., McLean C., Sykes J. E., Clement-Jones V. V., Lowry P. J. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem. 1981 Oct;117(1):136–146. doi: 10.1016/0003-2697(81)90703-x. [DOI] [PubMed] [Google Scholar]
  10. Scott A. P., Lowry P. J. Adrenocorticotrophic and melanocyte-stimulating peptides in the human pituitary. Biochem J. 1974 Jun;139(3):593–602. doi: 10.1042/bj1390593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wolfsen A. R., McIntyre H. B., Odell W. D. Adrenocorticotropin measurement by competitive binding receptor assay. J Clin Endocrinol Metab. 1972 Apr;34(4):684–689. doi: 10.1210/jcem-34-4-684. [DOI] [PubMed] [Google Scholar]
  12. YALOW R. S., GLICK S. M., ROTH J., BERSON S. A. RADIOIMMUNOASSAY OF HUMAN PLASMA ACTH. J Clin Endocrinol Metab. 1964 Nov;24:1219–1225. doi: 10.1210/jcem-24-11-1219. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES